Эндоваскулярное лечение эмболических осложнений фибрилляции предсердий: обзор литературы, клинические примеры

   Наиболее грозным осложнением фибрилляции предсердий (ФП) является системная артериальная эмболия. Высокая частота заболеваемости ФП, а также сохраняющийся риск эмболических осложнений даже на фоне антикоагулянтной терапии обусловливает актуальность данной проблемы и необходимость разработки комплексного подхода в ее решении. В целом, системные эмболии внецеребральной локализации встречаются реже, чем церебральной, однако они могут вызывать сопоставимые по тяжести ишемические осложнения с существенными различиями в клиническом течении в зависимости от локализации. В лечении внецеребральных кардиоэмболических осложнений в последнее время достигнут очевидный прогресс, обусловленный преимущественно развитием эндоваскулярных методов. Однако несовершенство диагностики и отсутствие четких алгоритмов применения методов порой обусловливают критические задержки в оказании помощи этой категории больных, что существенным образом влияет на прогноз заболевания.

1. Benjamin E.J., Muntner P., Alonso A., Bittencourt M.S., Callaway C.W., Carson A.P. et al., American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2019 update: a report from the American Heart Association. Circulation. 2019; 139: e56e528. DOI: 10.1161/CIR.0000000000000659

2. Chugh S.S., Havmoeller R., Narayanan K., Singh D., Rienstra M., Benjamin E.J. et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014; 129: 837847. DOI: 10.1161/CIRCULATIONAHA.113.005119

3. Lloyd-Jones D.M., Wang T.J., Leip E.P., Larson M.G., Levy D., Vasan R.S. et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004; 110 (09): 1042–6. DOI: 10.1161/01.CIR.0000140263.20897.42

4. Gawałko M., Kapłon-Cieślicka A., Hohl M., Dobrev D., Linz D. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. IJC Heart & Vasculature. 2020; 30: 10631. DOI: 10.1016/j.ijcha.2020.100631

5. Lip G.Y., Nieuwlaat R., Pisters R., Lane D.A. Crijns H.J. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010; 137 (2): 263–72. DOI: 10.1378/chest.09-1584

6. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Authors. Task Force. Eur. Heart J. 2020; 42: 373498. DOI: 10.1093/eurheartj/ehaa612 2020

7. Marijon E., Heuzey L., Connolly S., Yang S., Pogue J., Brueckmann M. et al.; for the RE-LY Investigators. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation. 2013; 128: 2192–201. DOI: 10.1161/CIRCULATIONAHA.112.000491

8. Суслина З.А., Варакин Ю.Я. Клиническое руководство по ранней диагностике, лечению и профилактике сосудистых заболеваний головного мозга. М.: МЕДпресс-информ; 2015.

9. Shpak M., Ramakrishnan A., Cowperthwaite M., Fanale C.H. Higher incidence of ischemic stroke in patients taking novel oral anticoagulants. Stroke. 2018; 49 (12): 2851–6. DOI: 10.1161/STROKEAHA.118.022636

10. Schäfer A., Flierl U., Berliner D., Bauersachs J. Anticoagulants for stroke prevention in atrial fibrillation in elderly patients. Cardiovasc. Drugs Ther. 2020; 34: 555–68. DOI: 10.1007/s10557-020-06981-3

11. Zhu W., Xiong Q., Hong K. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation. Tex. Heart Inst. J. 2015; 42 (1): 6–15. DOI: 10.14503/THIJ-14-4353

12. Frost L., Engholm G., Johnsen S., Møller H., Henneberg E.W., Husted S. et al. Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. Arch. Intern. Med. 2001; 161 (2): 272–6. DOI: 10.1001/archinte.161.2.272

13. Lip G.Y., Rumley A., Dunn F.G., Lowe G.D., Lowe G.D. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm. Int. J. Cardiol. 1995; 51 (3): 245–51. DOI: 10.1016/0167-5273(95)02434-x

14. Cambria R.P., Abbott W.M. Acute arterial thrombosis of the lower extremity. Its natural history contrasted with arterial embolism. Arch. Surg. 1984; 119 (7): 784–7. DOI: 10.1001/archsurg.1984.01390190028006

15. Grip O., Wanhainen A., Michaёlsson K., Lindhagen L., Björck M. Open or endovascular revascularization in the treatment of acute lower limb ischaemia. Br. J. Surg. 2018; 105: 1598e606. DOI: 10.1002/bjs.10954

16. Santistevan J.R. Acute limb ischemia: an emergency medicine approach. Emerg. Med. Clin. North. Am. 2017; 35: 889e909. DOI: 10.1016/j.emc.2017.07.006

17. Abbott W.M., Maloney R.D., McCabe C.C., Lee C.E., Wirthin L.S. et al. Arterial embolism: a 44 year perspective. Am. J. Surg. 1982; 143: 460–4. DOI: 10.1016/0002-9610(82)90196-9

18. Bekwelem W., Connolly S.J., Halperin J.L., Adabag S., Duval S., Chrolavicius S. et al. Extracranial systemic embolic events in patients with nonvalvular atrial fibrillation: incidence, risk factors, and outcomes. Circulation. 2015; 132: 796–803. DOI: 10.1161/CIRCULATIONAHA.114.013243

19. Shi M., Chen L.Y., Bekwelem W., Norby F.L., Soliman E.Z., Alam A.B., Alonso A. Association of atrial fibrillation with incidence of extracranial systemic embolic events: The ARIC Study. J. Am. Heart Assoc. 2020; 9 (18): e016724. DOI: 10.1161/JAHA.120.016724

20. Shibata T., Kawakami S., Noguchi T., Tanaka T., Asaumi Y., Kanaya T. et al. Prevalence, clinical features, and prognosis of acute myocardial infarction attributable to coronary artery embolism. Circulation. 2015; 132: 241–50. DOI: 10.1161/CIRCULATIONAHA.114.015134

21. Lacey M.J., Raza S., Rehman H., Puri R., Bhatt D.L., Kalra A. Coronary embolism : a systematic review. Cardiovasc. Revasc. Med. 2020; 21 (3): 367–74. DOI: 10.1016/j.carrev.2019.05.012

22. Kariyanna P.T., Ramalanjaona B., Al-Sadawi M., Jayarangaiah A., Hegde S., McFarlane I.M. et al. Coronary embolism and myocardial infarction: a scoping study. Am. J. Med. Case Rep. 2020; 8 (2): 31–43. DOI: 10.12691/ajmcr-8-2-1

23. Vlaar P., Svilaas T., van der Horst I., Diercks G.F., de Smet B.J., van den Heuvel A.F. et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet. 2008; 371: 1915–20.

24. Jolly S.S., Cairns J.A., Yusuf S., Rokoss M.J., Gao P., Meeks B. et al. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial. Lancet. 2016; 387: 127–35. DOI: 10.1016/S0140-6736(15)00448-1

25. Broderick J.P., Schroth G. What the SWIFT and TREVO II trials tell us about the role of endovascular therapy for acute stroke. Stroke. 2013; 44: 1761–4. DOI: 10.1161/STROKEAHA.113.000740

26. Манчуров В.Н., Анисимов К.В., Осканов М.Б., Скрыпник Д.В., Васильева Е.Ю., Шпектор А.В. Инфаркт миокарда эмболической природы. Кардиология. 2018; 58 (2): 83–90. DOI: 10.18087/cardio.2018.2.10090

27. Huang A.L., Murphy J.C., Shaw E., Kozor R., Wan W.W., Loxton A. et al. Routine aspiration thrombectomy improves the diagnosis and management of embolic myocardial infarction. Catheter. Cardiovasc. Interv. 2016; 87: 642–7. DOI: 10.1002/ccd.26047

28. Yeo L., Andersson T., Yee K.W., Tan B.Y., Paliwal P., Gopinathan A. et al. Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first? J. Thromb. Thrombolys. 2017; 44: 104–11. DOI: 10.1007/s11239-017-1484-2

29. Kawamura A., Lombardi D.A., Tilem M.E., Gossman D.E., Piemonte T.C., Nesto R.W. et al. Stroke complicating percutaneous coronary intervention in patients with acute myocardial infarction. Circ. J. 2007; 71: 1370–5. DOI: 10.1253/circj.71.1370

30. González-Pacheco H., Méndez-Domínguez A., Vieyra-Herrera G., Azar-Manzur F., Meave-González A., Rodríguezzanella H. et al. Reperfusion strategy for simultaneous ST-segment elevation myocardial infarction and acute ischemic stroke within a time window. Am. J. Emerg. Med. 2014; 32: 1157.e1–4. DOI: 10.1016/j.ajem.2014.02.047

31. Kijpaisalratana N., Chutinet A., Suwanwela N.C. Hyperacute simultaneous cardiocerebral infarction: rescuing the brain or the heart first? Front. Neurol. 2017; 8: 1–7. DOI: 10.3389/fneur.2017.00664

32. Tokuda K., Shindo S., Yamada K., Shirakawa M., Uchida K., Horimatsu T. et al. Acute embolic cerebral infarction and coronary artery embolism in a patient with atrial fibrillation caused by similar thrombi. J. Stroke Cerebrovasc. Dis. 2016; 25: 1797–9. DOI: 10.1016/j.jstrokecerebrovasdis.2016.01.055

33. De Castillo L., Diestro J.D., Tuazon C.A., Sy M.C., Añonuevo J.C., San Jose M.C. Cardiocerebral infarction: A single institutional series. J. Stroke Cerebrovasc. Dis. 2021; 30 (7): 105831 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105831

34. Лиманкина И.Н. Цереброкардиальный синдром. Вестник аритмологии. 2009; 58: 26–34.